{"name":"Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C.","slug":"fundaci-n-nacional-para-la-ense-anza-y-la-investigaci-n-de-la-dermatolog-a-a-c","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"pirfenidone 8% gel","genericName":"pirfenidone 8% gel","slug":"pirfenidone-8-gel","indication":"Localized skin fibrosis and scleroderma (topical indication in phase 3)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"silicon gel","genericName":"silicon gel","slug":"silicon-gel","indication":"Hypertrophic scars","status":"marketed"}]}],"pipeline":[{"name":"pirfenidone 8% gel","genericName":"pirfenidone 8% gel","slug":"pirfenidone-8-gel","phase":"phase_3","mechanism":"Pirfenidone reduces skin fibrosis and inflammation by inhibiting fibroblast proliferation and transforming growth factor-beta (TGF-β) signaling.","indications":["Localized skin fibrosis and scleroderma (topical indication in phase 3)"],"catalyst":""},{"name":"silicon gel","genericName":"silicon gel","slug":"silicon-gel","phase":"marketed","mechanism":"Silicon gel forms a protective barrier on the skin surface to reduce scar appearance and improve skin hydration.","indications":["Hypertrophic scars","Keloid scars","Post-surgical scars"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}